Access to and Barriers to Access for Essential Medicines in Nephrology and Related Non-Communicable Diseases: A Scoping Review Protocol
Michelle Wong(University of British Columbia), Vivekanand Jha(The George Institute for Global Health), Udeme E. Ekrikpo(University of Uyo), Stephanie Sanger(McMaster University), Nikhil Pereira-Kamath, Titi Chen(Westmead Hospital), Robert Kalyesubula(Africa Center), Eranga Wijewickrama(University of Colombo), Viviane Cálice-Silva(Universidade da Região de Joinville), Georges Nakoul(Cleveland Clinic), Anna Francis(Children's Health Queensland Hospital and Health Service), Elliot Koranteng Tannor(Kwame Nkrumah University of Science and Technology), Vivek Kumar(Post Graduate Institute of Medical Education and Research), Rahul Chanchlani(McMaster Children's Hospital), Muhammad Iqbal Abdul Hafidz(Universiti Teknologi MARA), Sabine Karam(American University of Beirut)
Cited by 0
Related Papers
Worldwide access to treatment for end-stage kidney disease: a systematic review
|The Lancet|2015|2.3k
Chronic kidney disease and the global public health agenda: an international consensus
|Nature Reviews Nephrology|2024|1.1k
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Nephrology Dialysis Transplantation|2019|587